Complex skin care for psoriasis: effective control with modern dermatocosmetic products
https://doi.org/10.21518/ms2023-273
Abstract
Introduction. Recent decades have witnessed significant progress in the dermatocosmetic industry, driven by increased knowledge of skin physiology, development of new active ingredients and products based on well-studied action mechanisms. Dermatovenerologists actively use dermatocosmetics in inflammatory skin diseases, which include psoriasis. Even in mild forms, psoriatic rashes can be accompanied by itching and flaking. A significant proportion of patients have lesions on exposed skin, and the disease has a severe psychosocial burden. Full and successful control of psoriasis requires the use of adjuvant agents, which can be used alone to maintain remission or as an adjunct to medication, also reducing the negative effects of treatment. The Kertyol P.S.O. Ducray range is represented by products containing active components with anti-inflammatory, antipruritic, keratoregulatory action.
Aim. To evaluate the effectiveness of including the Kertyol P.S.O. Ducray range of products in the treatment regimen of patients with psoriasis.
Materials and methods. 20 patients with localization of psoriatic rashes on smooth skin and scalp were included in the study. Kertyol P.S.O. Ducray concentrate in combination with calcipotriol was recommended for smooth skin rashes, and daily skin care was corrected; Kertyol P.S.O. Ducray concentrate and regenerating shampoo in combination with calcipotriol/betamethasone dipropionate were recommended for scalp skin.
Results. At the 4th week of therapy the average reduction of PASI index in the complex evaluation of clinical manifestations amounted to 89.6%; antipruritic effect was determined by the dynamics of VAS – the average reduction of the index at the 4th week amounted to 90.6%. Dermatologic life quality index (DLQI) decreased by 89.5% at the 4th week of therapy.
Conclusion. Kertyol P.S.O. Ducray products can be recommended as an effective adjuvant therapy for smooth skin and scalp psoriasis.
About the Authors
O. V. Zhukova
Peoples’ Friendship University of Russia;
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
Russian Federation
Russian Federation
Olga V. Zhukova, Dr. Sci. (Med.), Professor, Head of the Department of Dermatovenereology and Allergology with the Course of Immunology, Medicine Institute, 6, Miklukho-Maklai St., Moscow, 117198;
Chief Medical Officer, 17, Leninskiy Ave., Moscow, 119071
S. I. Artemyeva
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
Russian Federation
Russian Federation
Sofya I. Artemyeva, Researcher, Department of Clinical Dermatovenereology and Cosmetology, Dermatovenereologist,
17, Leninskiy Ave., Moscow, 119071
References
1. Potekaev NN, Zhukova OV, Artemyeva SI. Psoriasis: a personalized approach to therapy. The preferred choice of systemic agents considering comorbid pathologies. Meditsinskiy Sovet. 2020;(12):28–34. (In Russ.) https://doi.org/10.21518/2079-701X-2020-12-28-34.
2. Brandt FS, Cazzaniga A, Hann M. Cosmeceuticals: current trends and market analysis. Semin Cutan Med Surg. 2011;30(3):141–143. https://doi.org/10.1016/j.sder.2011.05.006.
3. Dreno B, Araviiskaia E, Berardesca E, Bieber T, Hawk J, Sanchez-Viera M, Wolkenstein P. The science of dermocosmetics and its role in dermatology. J Eur Acad Dermatol Venereol. 2014;28(11):1409–1417. https://doi.org/10.1111/jdv.12497.
4. Lv QW, Zhang W, Shi Q, Zheng WJ, Li X, Chen H et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Ann Rheum Dis. 2015;74(6):1078–1086. https://doi.org/10.1136/annrheumdis-2013-204807.
5. Wang Y, Lin Z, Zhang B, Jiang Z, Guo F, Yang T. Cichorium intybus L. Extract Suppresses Experimental Gout by Inhibiting the NF-κB and NLRP3 Signaling Pathways. Int J Mol Sci. 2019;20(19):4921. https://doi.org/10.3390/ijms20194921.
6. Thouvenin MD, Dalmon S, Theunis J, Lauze C, Coubetergues H, Mengeaud V, Calvet B. Tolerance and efficacy of a new celastrolcontaining balm as adjunct care in psoriasis. J Eur Acad Dermatol Venereol. 2020;34(Suppl. 6):10–16. https://doi.org/10.1111/jdv.16691.
7. Szepietowski JC, Reich A. Pruritus in psoriasis: An update. Eur J Pain. 2016;20(1):41–46. https://doi.org/10.1002/ejp.768.
Review
For citations:
Zhukova OV, Artemyeva SI. Complex skin care for psoriasis: effective control with modern dermatocosmetic products. Meditsinskiy sovet = Medical Council. 2023;(14):105-111. (In Russ.) https://doi.org/10.21518/ms2023-273
Views:
358
Email this article 